Compare Johnson & Johnson (JNJ) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Zillow Group Inc Class C — how do they compare? Johnson & Johnson trades at $260.77 (market cap $626.09B), while Zillow Group Inc Class C trades at $33.27 (market cap $7.68B). The key difference: Johnson & Johnson is far larger — about 81.5× Zillow Group Inc Class C's market cap, and Johnson & Johnson pays a 2.06% dividend while Zillow Group Inc Class C pays none. Which is the better fit depends on your goals.
| JNJ | Z | |
|---|---|---|
Market Cap | $626.09B | $7.68B |
Volume | 6,156,228 | — |
Sector | Health | Media |
52-Week High | $267.24 | $90.35 |
52-Week Low | $172.78 | $29.41 |
Enterprise Value | $654.37B | $7.56B |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Zillow Group (Z) trades at $33.26, down 1.45% on the day, amid a bearish technical signal and mixed sentiment. The stock shows strong revenue growth, with Q2 2026 results beating expectations, but faces near-term pressure from a securities class action lawsuit. Valuation metrics like a P/E of 148.41 reflect high growth expectations, while profitability remains modest with a net income margin of 1.96%.
The outlook is cautious; analyst consensus targets $52.00, implying upside, but legal risks and a challenging real estate market pose headwinds. Investors should weigh the company's monetization progress against litigation overhangs and macroeconomic sensitivity for balanced risk-reward assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
